Laurion Capital Management LP Dyne Therapeutics, Inc. Transaction History
Laurion Capital Management LP
- $7.27 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
207Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$113 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$104 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$97 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$96.3 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$96.3 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $731M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...